Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 7Sarcoma 6Lymphoid 6Genitourinary 5Tumor-Agnostic 4Other hematologic neoplasm 4Plasma cell 3CNS 3Thoracic 2Other solid neoplasm 2Myeloid 2Gynecologic 2Breast 2Dermatologic 1

Conditions

Neoplasms 4

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × perifosine × Tumor-Agnostic × Clear all
NCT01224730 2018-03-14

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

AEterna Zentaris

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasms

NCT00398697 2014-02-13

Phase I Perifosine and Gemcitabine Study

AEterna Zentaris

Phase 1 Completed
19 enrolled
Tumor-Agnostic

Neoplasms

NCT00399087 2014-02-13

Phase I Trial of Docetaxel With Perifosine

AEterna Zentaris

Phase 1 Completed
39 enrolled
Tumor-Agnostic

Neoplasms

NCT00399126 2014-02-13

Phase I Trial of Paclitaxel With Perifosine

AEterna Zentaris

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡